1887

Abstract

Human immunodeficiency virus type 1 has several genetic subtypes and two coreceptor use phenotypes: R5 that uses CCR5, while X4 uses CXCR4. A high amino acid charge of the envelope glycoprotein 120 V3 region, common at positions 11 and 25, is important for CXCR4 use. We characterized charged V3 amino acids, retrieving all biologically phenotyped sequences from the HIV Sequence Database. Selecting individually unique ones randomly yielded 48 subtype A, 231 B, 180 C, 37 D and 32 CRF01_AE sequences; 482 were R5 and 46 were X4. Charged amino acids were conserved in both R5 and X4 with general and subtype-specific patterns. X4 viruses gained a higher charge from positive amino acids at positions other than in R5, and through the loss of negative amino acids. Other positions than 11/25 had a greater impact on charge (<0.001). This describes how R5 evolves into X4 in a subtype-specific context, useful for computer-based predictions and vaccine design.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.029447-0
2011-08-01
2024-12-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/8/1917.html?itemId=/content/journal/jgv/10.1099/vir.0.029447-0&mimeType=html&fmt=ahah

References

  1. Baeten J. M., Chohan B., Lavreys L., Chohan V., McClelland R. S., Certain L., Mandaliya K., Jaoko W., Overbaugh J. 2007; HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195:1177–1180 [View Article][PubMed]
    [Google Scholar]
  2. Berger E. A., Doms R. W., Fenyö E. M., Korber B. T., Littman D. R., Moore J. P., Sattentau Q. J., Schuitemaker H., Sodroski J., Weiss R. A. 1998; A new classification for HIV-1. Nature 391:240 [View Article][PubMed]
    [Google Scholar]
  3. Casper C., Navér L., Clevestig P., Belfrage E., Leitner T., Albert J., Lindgren S., Ottenblad C., Bohlin A. B. et al. 2002; Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes. AIDS Res Hum Retroviruses 18:343–352 [View Article][PubMed]
    [Google Scholar]
  4. Chesebro B., Wehrly K., Nishio J., Perryman S. 1992; Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 66:6547–6554[PubMed]
    [Google Scholar]
  5. Clevestig P., Pramanik L., Leitner T., Ehrnst A. 2006; CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site. J Gen Virol 87:607–612 [View Article][PubMed]
    [Google Scholar]
  6. Connor R. I., Sheridan K. E., Ceradini D., Choe S., Landau N. R. 1997; Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185:621–628 [View Article][PubMed]
    [Google Scholar]
  7. de Jong J. J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., de Ronde A. 1992a). Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 66:757–765[PubMed]
    [Google Scholar]
  8. de Jong J. J., De Ronde A., Keulen W., Tersmette M., Goudsmit J. 1992b). Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol 66:6777–6780[PubMed]
    [Google Scholar]
  9. De Wolf F., Hogervorst E., Goudsmit J., Fenyö E. M., Rübsamen-Waigmann H., Holmes H., Galvão-Castro B., Karita E., Wasi C. et al. 1994; Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res Hum Retroviruses 10:1387–1400 [View Article][PubMed]
    [Google Scholar]
  10. Easterbrook P. J., Smith M., Mullen J., O’Shea S., Chrystie I., de Ruiter A., Tatt I. D., Geretti A. M., Zuckerman M. 2010; Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc 13:4 [View Article][PubMed]
    [Google Scholar]
  11. Fouchier R. A., Groenink M., Kootstra N. A., Tersmette M., Huisman H. G., Miedema F., Schuitemaker H. 1992; Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 66:3183–3187[PubMed]
    [Google Scholar]
  12. Huang W., Eshleman S. H., Toma J., Fransen S., Stawiski E., Paxinos E. E., Whitcomb J. M., Young A. M., Donnell D. et al. 2007; Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 81:7885–7893 [View Article][PubMed]
    [Google Scholar]
  13. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. 1991; Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71–74 [View Article][PubMed]
    [Google Scholar]
  14. Kiwanuka N., Robb M., Laeyendecker O., Kigozi G., Wabwire-Mangen F., Makumbi F. E., Nalugoda F., Kagaayi J., Eller M. et al. 2010; HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 54:180–184[PubMed]
    [Google Scholar]
  15. Koot M., Keet I. P., Vos A. H., de Goede R. E., Roos M. T., Coutinho R. A., Miedema F., Schellekens P. T., Tersmette M. 1993; Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 118:681–688[PubMed] [CrossRef]
    [Google Scholar]
  16. Ogert R. A., Lee M. K., Ross W., Buckler-White A., Martin M. A., Cho M. W. 2001; N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 75:5998–6006 [View Article][PubMed]
    [Google Scholar]
  17. Pollakis G., Kang S., Kliphuis A., Chalaby M. I., Goudsmit J., Paxton W. A. 2001; N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 276:13433–13441 [View Article][PubMed]
    [Google Scholar]
  18. Polzer S., Dittmar M. T., Schmitz H., Meyer B., Müller H., Kräusslich H. G., Schreiber M. 2001; Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology 11:11–19 [View Article][PubMed]
    [Google Scholar]
  19. Polzer S., Dittmar M. T., Schmitz H., Schreiber M. 2002; The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Virology 304:70–80 [View Article][PubMed]
    [Google Scholar]
  20. Resch W., Hoffman N., Swanstrom R. 2001; Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology 288:51–62 [View Article][PubMed]
    [Google Scholar]
  21. Scarlatti G., Tresoldi E., Björndal A., Fredriksson R., Colognesi C., Deng H. K., Malnati M. S., Plebani A., Siccardi A. G. et al. 1997; In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3:1259–1265 [View Article][PubMed]
    [Google Scholar]
  22. Shioda T., Levy J. A., Cheng-Mayer C. 1992; Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 89:9434–9438 [View Article][PubMed]
    [Google Scholar]
  23. Vasan A., Renjifo B., Hertzmark E., Chaplin B., Msamanga G., Essex M., Fawzi W., Hunter D. 2006; Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 42:843–852 [View Article][PubMed]
    [Google Scholar]
  24. Zhu T., Mo H., Wang N., Nam D. S., Cao Y., Koup R. A., Ho D. D. 1993; Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179–1181 [View Article][PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.029447-0
Loading
/content/journal/jgv/10.1099/vir.0.029447-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error